4//SEC Filing
Altimmune, Inc. 4
Accession 0000899243-17-012362
$ALTCIK 0001326190operating
Filed
May 7, 8:00 PM ET
Accepted
May 8, 8:37 PM ET
Size
14.3 KB
Accession
0000899243-17-012362
Insider Transaction Report
Form 4
Altimmune, Inc.NASDAQ:ALT
Redmont Venture Partners, Inc.
10% Owner
Transactions
- Award
Common Stock, par value $0.0001
2017-05-04+4,455→ 4,455 total(indirect: See Footnote) - Award
Common Stock, par value $0.0001
2017-05-04+1,278,471→ 1,278,471 total(indirect: See Footnote) - Award
Common Stock, par value $0.0001
2017-05-04+36,785→ 36,785 total(indirect: See Footnote)
Transactions
- Award
Common Stock, par value $0.0001
2017-05-04+1,278,471→ 1,278,471 total(indirect: See Footnote) - Award
Common Stock, par value $0.0001
2017-05-04+4,455→ 4,455 total(indirect: See Footnote) - Award
Common Stock, par value $0.0001
2017-05-04+36,785→ 36,785 total(indirect: See Footnote)
Paradigm Venture Partners, L.P.
10% Owner
Transactions
- Award
Common Stock, par value $0.0001
2017-05-04+4,455→ 4,455 total(indirect: See Footnote) - Award
Common Stock, par value $0.0001
2017-05-04+1,278,471→ 1,278,471 total(indirect: See Footnote) - Award
Common Stock, par value $0.0001
2017-05-04+36,785→ 36,785 total(indirect: See Footnote)
Hodges Philip
Director
Transactions
- Award
Common Stock, par value $0.0001
2017-05-04+36,785→ 36,785 total(indirect: See Footnote) - Award
Common Stock, par value $0.0001
2017-05-04+4,455→ 4,455 total(indirect: See Footnote) - Award
Common Stock, par value $0.0001
2017-05-04+1,278,471→ 1,278,471 total(indirect: See Footnote)
Footnotes (4)
- [F1]Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the "Merger Agreement"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. ("Altimmune"). Pursuant to the Merger Agreement, the then outstanding shares of Altimmune's capital stock was converted into the right to receive a number of shares of the Issuer's common stock, par value $0.0001 on a 0.749106:1 basis upon the closing of the merger.
- [F2]Consists of shares of Common Stock held by Redmont VAXN Capital Holdings, LLC, a Delaware limited liability company ("RVCH"). Philip Hodges has sole voting and dispositive control with respect to all securities held by RVCH. Mr. Hodges disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
- [F3]Consists of shares of Common Stock held by Redmont Venture Partners, Inc., a Delaware corporation ("RVP"). Mr. Hodges has sole voting and dispositive control with respect to all securities held by RVP. Mr. Hodges disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
- [F4]Consists of shares of Common Stock held by Paradigm Venture Partners, L.P., a Delaware limited partnership ("PVP"). Mr. Hodges has sole voting and dispositive control with respect to all securities held by PVP. Mr. Hodges disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001326190
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 8:37 PM ET
- Size
- 14.3 KB